Implementation of green analytical principles to develop and validate the HPLC method for the Anticancer drug in Pharmaceutical formulations.
Main Article Content
Keywords
immune-modulating, anti-angiogenic, HPLC, Lenalidomide, ICH guidelines
Abstract
Lenalidomide is a drug that has immune-modulating, anti-angiogenic, and anti-inflammatory properties. In this study, we developed green HPLC and spectrophotometric methods to determine the concentration of lenalidomide in pure and pharmaceutical formulations. In the HPLC method, 10 mM potassium dihydrogen phosphate solution (pH: 2.0) and ethanol (50:50, V/V) were used as mobile phases, isocratic elution was applied at a flow rate of 1.0 mL min−1 and detection was made at 304 nm. In the spectrophotometric method, the spectral patterns of standard solutions in different solvents were comprehensively examined, the best spectra were obtained with ultrapure water, and a wavelength of 304 nm was selected for detection. Both methods have been validated according to ICH guidelines for various parameters. Correlation coefficients greater than 0.999 were determined for both methods in the concentration range of 5–30 μg mL−1. The developed methods were applied to commercial formulations, and comparisons of the results were made using the Student (t) test for means and the Fischer (F) test for standard deviations. No statistically significant difference was observed between the methods. The greenness evaluation of these methods was carried out using AGREE software. The developed methods are proposed as excellent environmental and operator-friendly alternatives for the quantification of Lenalidomide in pharmaceutical formulations.
References
[2] Koel, M.; Kaljurand, M. Application of the principles of green chemistry in analytical chemistry. Pure Appl. Chem. 2006, 78, 1993–2002. https://doi.org/10.1351/pac200678111993.
[3] Tobiszewski, M.; Mechlinska, A.; Namiesnik, J. Green analytical chemistry – theory and practice. Chem. Soc. Rev. 2010, 39, 2869–78. https://doi.org/10.1039/B926439F.
[4] Gałuszka, A.; Migaszewski, Z.; Namiesnik, J. The 12 principles of green analytical chemistry and the SIGNIFICANCE mnemonic of green analytical practices. TRAC-Trend, Anal. Chem. 2013, 50, 78–84. https://doi.org/10.1016/j.trac.2013.04.010.
[5] Płotka, J.; Tobiszewski, M.; Sulej, A. M.; Kupska, M.; Gorecki, T.; Namiesnik, J. Green chromatography. J. Chromatogr. A. 2013, 1307, 1–20. https://doi.org/10.1016/j.chroma.2013.07.099.
[6] Sangoi, M. S.; Todeschini, V.; Steppe, M. Second-order derivative UV spectrophotometric method for the determination of fesoterodine and comparison with LC, CE, and LC-MS/MS in commercial extended-release tablets. Acta Chim. Slov 2012, 59, 136–43.
[7] Ashour, S.; Bayram, R. Selective and validated kinetic spectrophotometric method for the determination of irbesartan in pure and pharmaceutical formulations. Ann. Pharm. Fr 2019, 77(2), 101–11.
[8] Corte, A. C.; Sfair, L. L. Development and validation of analytical methodology for quality evaluation of tibolone in capsule pharmaceutical form through UV spectrophotometry. Drug Anal. Res. 2019, 3(2), 7–11.
[9] Gomes, P.; Negretto, C. M. U.; Naisinger, Z. B.; Lorenzoni, R.; Wingert, N. R.; Raffin, R. P. Second-derivative spectrophotometry for the analysis of simvastatin in polymeric Nanocapsules. Drug Anal Res. 2019, 3(2), 12–7.
[10] Oppe, T. P.; Menegola, J.; Schapoval, E. E. S. Development and validation of UV spectrophotometry and liquid chromatography methods for determination of cefpirome in raw material and pharmaceutical dosage. Drug Anal Res. 2019, 3(1), 42–50.
[11] Naguib, A. I.; Abdelaleem, E. A.; Hassan, E. S. Comparative study of eco-friendly spectrophotometric methods for accurate quantification of mebendazole and quinfamide combination; Content uniformity evaluation. Spectrochim Acta A 2020, 235, 1–10.
[12] Darwish, H. W.; Ali, N. A.; Naguib, I. A.; Ghobashy, M. R. E.; Al-Hossaini, A. M.; Abdelrahman, M. M. Stability indicating spectrophotometric methods for the quantitative determination of bromazepam and its degradation product. Spectrochim Acta A 2020, 238, 1–10.
[13] Görög, S. The changing face of pharmaceutical analysis. TrAC Trends Anal. Chem. 2007, 26, 12–7.
[14] Snyder, L. R.; Kirkland, J. J.; Dolan, J. W. Introduction to Modern Liquid Chromatography; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2009, ISBN 978-0-470-50818-3.
[15] Welch, C. J.; Wu, N.; Biba, M.; Hartman, R.; Brkovic, T.; Gong, X.; Helmy, R.; Schafer, W.; Cuff, J.; Pirzada, Z. Greening analytical chromatography. TrAC Trends Anal. Chem. 2010, 29, 667–80.
[16] ICH Harmonised Tripartite Guideline Impurities: Guideline for residual solvents Q3C (R5). Curr. Step 2005, 4, 509.
[17] Sheldon, R. A. Fundamentals of green chemistry: efficiency in reaction design. Chem. Soc. Rev. 2012, 41, 1437–51.
[18] Tobiszewski, M. Metrics for green analytical chemistry. Anal Methods 2016, 8, 2993–9.
[19] Prat, D.; Hayler, J.; Wells, A. A survey of solvent selection guides. Green. Chem. 2014, 16, 4546–51.
[20] Ette, E.; Zhou, S.; Weiss, D.; Palmisano, M. Population pharmacokinetics and exposure-safety of lenalidomide in patients with multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. Blood 2013, 122, 3234. https://doi.org/10.13140/RG.2. 2.16459.08481